Addex to Present at the Virtual German Equity Forum

Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149

Addex to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference

Addex Reports Q3 2021 Financial Results and Provides Corporate Update

Addex Therapeutics to Release Q3 2021 Financial Results and Host Conference Call on November 4, 2021

Addex to Present at the Investors’ Day hosted by Voxia Communication

Addex to Present at the 10th International Meeting on Metabotropic Glutamate Receptors

Addex Therapeutics Initiates Phase 2 Clinical Study with Dipraglurant in Blepharospasm

Addex to Present at the Cantor Global Healthcare 2021 Conference

CMTA and Addex Therapeutics Enter Collaboration to Advance GABA B PAM as Potential Treatment for CMT1A